In Loving Memory of
Carrie is an inspiring light for all of the friends and colleagues who had the privilege of working with her at AstraZeneca.
Her passion for translational science and her selfless dedication to the development of new medicines shone brightly. In over 50 countries around the world men with prostate cancer have access to a new medicine, Olaparib, as a direct result of Carrie’s outstanding scientific drive and intellect.
An enduring legacy has been created by Carrie through her brilliance in science and in her kindness in advising colleagues. Through this legacy Carrie will continue to impact the lives of cancer patients for many years to come.
– Liz Harrington